Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Impact of Right-sided Obstructive Lesions in Children & Adolescents having Cone Repair for Ebstein Anomaly
Hu, Jessie J. , Dorn, Charlotte S. Van , Rohatgi, Ram K., Anderson, Heather N., Wackel, Philip L. , Cetta, Frank , Johnson, Jonathan N. , Dearani, Joseph A.

Mayo Clinic

Pediatrics | March 1, 2023 | Volume: 146 | Issue: 1_MeetingAbstract | Pages: 615-616

10.1542/peds.146.1ma7.615 Get It

Gender Differences in Morphology, Disease Phenotype and Outcomes Among Children and Young Adults with Bicuspid Aortic Valve
Hagler, Donald J. , Poterucha, Joseph T., Cetta, Frank , Johnson, Jonathan N. , Niaz, Talha

Mayo Clinic

Pediatrics | March 1, 2023 | Volume: 146 | Issue: 1_MeetingAbstract | Pages: 601-601

10.1542/peds.146.1ma7.601a Get It

The Role of Cardiac Transplantation in Reversing Fontan Associated Liver Disease: A Case Report
Sessions, Kristen L., Hilscher, Moira , Cetta, Frank , Kamath, Patrick S. , Poterucha, John J., Ameduri, Rebecca , Johnson, Jonathan N.

Mayo Clinic

Pediatrics | March 1, 2023 | Volume: 141 | Issue: 1_MeetingAbstract | Pages: 704-704

10.1542/peds.141.1ma8.704 Get It

Platelet‐Rich Plasma and Marrow Venting May Serve as Cost‐Effective Augmentation Techniques for Isolated Meniscal Repair: A Decision‐Analytical Markov Model–Based Analysis
Oeding, Jacob F. , Berlinberg, Elyse J. , Marigi, Erick M. , Okoroha, Kelechi R. , Camp, Christopher L. , Barlow, Jonathan D. , Krych, Aaron J. , Camp, Christopher L. , Krych, Aaron J , Marigi, Erick , Barlow, Jonathan D , Oeding, Jacob F , Lu, Yining

Mayo Clinic

Arthroscopy | March 1, 2023 | Volume: 39 | Issue: 9 | Pages: 2058-2068

10.1016/j.arthro.2023.02.018 | PMID 36868533 Get It

Purpose To evaluate the cost‐effectiveness of 3 isolated meniscal repair (IMR) treatment strategies: platelet‐rich plasma (PRP)–augmented IMR, IMR with a marrow venting procedure (MVP), and IMR without biological augmentation. Methods A Markov model was developed to evaluate the baseline case: a young adult patient meeting the indications for IMR. Health utility values, failure rates, and transition probabilities were derived from the published literature. Costs were determined based on the typical patient undergoing IMR at an outpatient surgery center. Outcome measures included costs, quality‐adjusted life‐years (QALYs), and the incremental cost‐effectiveness ratio (ICER). Results Total costs of IMR with an MVP were $8,250; PRP‐augmented IMR, $12,031; and IMR without PRP or an MVP, $13,326. PRP‐augmented IMR resulted in an additional 2.16 QALYs, whereas IMR with an MVP produced slightly fewer QALYs, at 2.13. Non‐augmented repair produced a modeled gain of 2.02 QALYs. The ICER comparing PRP‐augmented IMR versus MVP‐augmented IMR was $161,742/QALY, which fell well above the $50,000 willingness‐to‐pay threshold. Conclusions IMR with biological augmentation (MVP or PRP) resulted in a higher number of QALYs and lower costs than non‐augmented IMR, suggesting that biological augmentation is cost‐effective. Total costs of IMR with an MVP were significantly lower than those of PRP‐augmented IMR, whereas the number of additional QALYs produced by PRP‐augmented IMR was only slightly higher than that produced by IMR with an MVP. As a result, neither treatment dominated over the other. However, because the ICER of PRP‐augmented IMR fell well above the $50,000 willingness‐to‐pay threshold, IMR with an MVP was determined to be the overall cost‐effective treatment strategy in the setting of young adult patients with isolated meniscal tears. Level of Evidence Level III, economic and decision analysis.
Acute penile pain as a presentation of pulmonary embolism: a case report
Leff, Rebecca , Milojkovic, Klara, O’Sullivan, Donnchadh , Schwartz, Jonathan , Leng, Tomas , Schwartz, Jonathan, Anderson, Jana J.

Mayo Clinic

No container title available | March 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2610249/v1 Get It

Abstract Background Pulmonary embolism (PE) in the pediatric population is uncommon, and due to a silent presentation often unrecognized entity that remains one of the most challenging medical conditions in the emergency department (ED). Risk factors for PE in children include nephrotic syndrome, immobility, obesity, congenital heart disease, and malignancy. In patients with PE, thromboembolism has been reported to occur at unusual venous sites including the veins within the central nervous system and abdomen. Although penile pain is a rare presenting symptom in the ED, in patients with hypercoagulability, it can herald a life threating event such as PE prompting further evaluation. Case presentation A 15-year-old male with a history of B-cell acute lymphoblastic leukemia who presented to the ED with an 18-hour history of penile pain. In the ED, the patient was in acute distress and rated his pain as 9/10. Initial vital signs were within normal limits, except mild tachypnea. On physical examination, his penile shaft was erythematous, indurated, and tender to palpation. He received fentanyl and morphine for pain. A complete blood cell count revealed pancytopenia with a platelet count of 73 x 109/L (139–320 x 109/L). A work-up for sexually transmitted diseases, urolithiasis, urinary tract infection, deep venous thrombosis (DVT), and priapism was negative. Approximately two hours after morphine administration, his saturations started dropping to mid-70’s. A computed tomography pulmonary angiogram (CTPA) revealed bilateral segmental acute pulmonary embolism involving multiple segmental right and left lower lobe pulmonary arteries. Penile pain and hypoxia have resolved with heparin. Conclusions PE is easily missed diagnosis among children who present to the ED and can be potentially fatal. A high index of suspicion is required in asymptomatic and oligo-symptomatic children with prothrombotic risk factors who develop thromboembolism-related symptoms at unusual sites as well as hypoxia in the ED setting.
ICU Outcomes for Cone Reconstruction in Children with Ebstein Anomaly
Anderson, Heather N., Dorn, Charlotte S. Van , Haggerty, Brielle J., Wackel, Philip L. , Cetta, Frank , Johnson, Jonathan N. , Dearani, Joseph A. , Nemergut, Michael E.

Mayo Clinic

Pediatrics | February 28, 2023 | Volume: 144 | Issue: 2_MeetingAbstract | Pages: 318-318

10.1542/peds.144.2ma4.318b Get It

Impact of Left-sided Lesions in Pediatric Patients Having Surgery for Ebstein Anomaly
Haggerty, Brielle J., Dorn, Charlotte S. Van , Anderson, Heather N., Wackel, Philip L. , Cetta, Frank , Johnson, Jonathan N. , Dearani, Joseph A.

Mayo Clinic

Pediatrics | February 28, 2023 | Volume: 144 | Issue: 2_MeetingAbstract | Pages: 294-294

10.1542/peds.144.2ma3.294 Get It

KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression
Meliambro, Kristin, Yang, Yanfeng , Cos, Marina de , Ballestas, Estefania Rodriguez , Malkin, Caroline, Haydak, Jonathan C. , Lee, John R. , Salem, Fadi , Mariani, Laura , Gordon, Ronald E., Basgen, John M. , Wen, Huei Hsun , Fu, Jia , Azeloglu, Evren U. , He, John Cijiang , Wong, Jenny, Salem, Fadi E , He, Cijiang , Campbell, Kirk Nicholas

Mayo Clinic

JCI Insight | February 28, 2023 | Volume: 8 | Issue: 7 | Pages: No page available

10.1172/jci.insight.165002 | PMID 36853804 Get It

Despite recent progress in the identification of mediators of podocyte injury, mechanisms underlying podocyte loss remain poorly understood, and cell-specific therapy is lacking. We previously reported that kidney and brain expressed protein (KIBRA), encoded by WWC1 , promotes podocyte injury in vitro through activation of the Hippo signaling pathway. KIBRA expression is increased in the glomeruli of patients with focal segmental glomerulosclerosis, and KIBRA depletion in vivo is protective against acute podocyte injury. Here, we tested the consequences of transgenic podocyte-specific WWC1 expression in immortalized human podocytes and in mice, and we explored the association between glomerular WWC1 expression and glomerular disease progression. We found that KIBRA overexpression in immortalized human podocytes promoted cytoplasmic localization of Yes-associated protein (YAP), induced actin cytoskeletal reorganization, and altered focal adhesion expression and morphology. WWC1 -transgenic (KIBRA-overexpressing) mice were more susceptible to acute and chronic glomerular injury, with evidence of YAP inhibition in vivo. Of clinical relevance, glomerular WWC1 expression negatively correlated with renal survival among patients with primary glomerular diseases. These findings highlight the importance of KIBRA/YAP signaling to the regulation of podocyte structural integrity and identify KIBRA-mediated injury as a potential target for podocyte-specific therapy in glomerular disease.
Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease
Li, Yan , Barthélemy, Nicolas R. , Gordon, Brian A. , Hassenstab, Jason , Fagan, Anne M. , Morris, John C. , Xiong, Chengjie , Méndez, Patricio Chrem, Noble, James M. , Farlow, Martin R. , Chhatwal, Jasmeer P. , Day, Gregory S. , Masters, Colin L. , Roh, Jee Hoon , Sachdev, Pallavi, Koyama, Akihiko , Reyderman, Larisa, Bateman, Randall J. , Network, and the Dominantly Inherited Alzheimer, Sachdev, Perminder S. , Vöglein, Jonathan , Gordon, Brian A , Kasuga, Kensaku , Day, Gregory S , Jucker, Mathias , Roh, Jee Hoon , Sato, Chihiro , McDade, Eric M , Sachdev, Perminder S , Bateman, Randall J , Masters, Colin L , Vöglein, Jonathan , Xiong, Chengjie , Hassenstab, Jason , Morris, John C , Noble, James M , Horie, Kanta , Li, Yan, Benzinger, Tammie L.S. , Karch, Celeste M. , Xiong, Chengjie , Allegri, Ricardo , Ikeuchi, Takeshi , Schofield, Peter R. , Lee, Jae‐Hong , Sachdev, Pallavi, McDade, Eric , Network, and the Dominantly Inherited Alzheimer

Mayo Clinic

Annals of Neurology | February 27, 2023 | Volume: 93 | Issue: 6 | Pages: 1158-1172

10.1002/ana.26620 | PMID 36843330 Get It

ObjectiveIdentifying cerebrospinal fluid measures of the microtubule binding region of tau (MTBR‐tau) species that reflect tau aggregation could provide fluid biomarkers that track Alzheimer's disease related neurofibrillary tau pathological changes. We examined the cerebrospinal fluid (CSF) MTBR‐tau species in dominantly inherited Alzheimer's disease (DIAD) mutation carriers to assess the association with Alzheimer's disease (AD) biomarkers and clinical symptoms.MethodsCross‐sectional and longitudinal CSF from 229 DIAD mutation carriers and 130 mutation non‐carriers had sequential characterization of N‐terminal/mid‐domain phosphorylated tau (p‐tau) followed by MTBR‐tau species and tau positron emission tomography (tau PET), other soluble tau and amyloid biomarkers, comprehensive clinical and cognitive assessments, and brain magnetic resonance imaging of atrophy.ResultsCSF MTBR‐tau species located within the putative “border” region and one species corresponding to the “core” region of aggregates in neurofibrillary tangles (NFTs) increased during the presymptomatic stage and decreased during the symptomatic stage. The “border” MTBR‐tau species were associated with amyloid pathology and CSF p‐tau; whereas the “core” MTBR‐tau species were associated stronger with tau PET and CSF measures of neurodegeneration. The ratio of the border to the core species provided a continuous measure of increasing amounts that tracked clinical progression and NFTs.InterpretationChanges in CSF soluble MTBR‐tau species preceded the onset of dementia, tau tangle increase, and atrophy in DIAD. The ratio of 4R‐specific MTBR‐tau (border) to the NFT (core) MTBR‐tau species corresponds to the pathology of NFTs in DIAD and change with disease progression. The dynamics between different MTBR‐tau species in the CSF may serve as a marker of tau‐related disease progression and target engagement of anti‐tau therapeutics. ANN NEUROL 2023;93:1158–1172
Dynamic NIR Fluorescence Imaging and Machine Learning Framework for Stratifying High vs. Low Notch-Dll4 Expressing Host Microenvironment in Triple-Negative Breast Cancer
Shafiee, Shayan , Jagtap, Jaidip , Zayats, Mykhaylo , Epperlein, Jonathan P. , Banerjee, Anjishnu , Geurts, Aron M. , Flister, Michael J. , Zhuk, Sergiy , Epperlein, Jonathan , Shafiee, Shayan , Banerjee, Anjishnu , Joshi, Amit

Mayo Clinic

Cancers | February 27, 2023 | Volume: 15 | Issue: 5 | Pages: 1460

10.3390/cancers15051460 | PMID 36900252 Get It

Delta like canonical notch ligand 4 (Dll4) expression levels in tumors are known to affect the efficacy of cancer therapies. This study aimed to develop a model to predict Dll4 expression levels in tumors using dynamic enhanced near-infrared (NIR) imaging with indocyanine green (ICG). Two rat-based consomic xenograft (CXM) strains of breast cancer with different Dll4 expression levels and eight congenic xenograft strains were studied. Principal component analysis (PCA) was used to visualize and segment tumors, and modified PCA techniques identified and analyzed tumor and normal regions of interest (ROIs). The average NIR intensity for each ROI was calculated from pixel brightness at each time interval, yielding easily interpretable features including the slope of initial ICG uptake, time to peak perfusion, and rate of ICG intensity change after reaching half-maximum intensity. Machine learning algorithms were applied to select discriminative features for classification, and model performance was evaluated with a confusion matrix, receiver operating characteristic curve, and area under the curve. The selected machine learning methods accurately identified host Dll4 expression alterations with sensitivity and specificity above 90%. This may enable stratification of patients for Dll4 targeted therapies. NIR imaging with ICG can noninvasively assess Dll4 expression levels in tumors and aid in effective decision making for cancer therapy.